Followers | 504 |
Posts | 10140 |
Boards Moderated | 0 |
Alias Born | 04/28/2014 |
Sunday, September 13, 2015 11:03:48 AM
bullish
http://investors.xbiotech.com/phoenix.zhtml?c=253990&p=irol-irhome
## source: finance.yahoo.com
Thu, 03 Sep 2015 18:25:05 GMT ~ XBiotech Advances Phase 1/2 Clinical Study of Novel True Human™ Therapeutic Antibody for Treating Serious Infections Due to Staphylococcus aureus
[at noodls] - 0 1 09.01.15 - XBiotech Advances Phase 1/2 Clinical Study of Novel True Human™ Therapeutic Antibody for Treating Serious Infections Due to Staphylococcus aureus Company Begins Second Dosing Cohort in Dose ...
read full: http://www.noodls.com/view/9D608417956F1E5A96B8A7E2D2731EF41A5D9D7B
*********************************************************
Tue, 01 Sep 2015 11:00:00 GMT ~ XBiotech Advances Phase 1/2 Clinical Study of Novel True Human(TM) Therapeutic Antibody for Treating Serious Infections Due to Staphylococcus Aureus
[GlobeNewswire] - AUSTIN, Texas -- XBiotech (NASDAQ:XBIT), the world's leading developer of next-generation True Human(TM) therapeutic antibodies, announced today the completion of the first cohort in its Phase 1/2 clinical ...
read full: http://finance.yahoo.com/news/xbiotech-advances-phase-1-2-110000369.html
*********************************************************
Mon, 24 Aug 2015 15:52:56 GMT ~ Edited Transcript of XBIT earnings conference call or presentation 28-Jul-15 12:30pm GMT
read full: http://finance.yahoo.com/news/edited-transcript-xbit-earnings-conference-155256063.html
*********************************************************
Mon, 17 Aug 2015 15:33:08 GMT ~ XBiotech Completes Enrollment for Xilonix™ Phase III Registration Study in Europe
[at noodls] - 0 1 08.17.15 - XBiotech (NASDAQ: XBIT), the world's leading developer of next-generation True Human™ therapeutic antibodies, announced today it has completed enrollment of the Company's pivotal, randomized ...
read full: http://www.noodls.com/view/69FB7C4EAD80644D19DC2AC21A15AE738FB6138C
*********************************************************
Mon, 17 Aug 2015 11:00:00 GMT ~ XBiotech Completes Enrollment for Xilonix(TM) Phase III Registration Study in Europe
[GlobeNewswire] - AUSTIN, Texas -- XBiotech (NASDAQ:XBIT), the world's leading developer of next-generation True Human(TM) therapeutic antibodies, announced today it has completed enrollment of the Company's pivotal, randomized ...
read full: http://finance.yahoo.com/news/xbiotech-completes-enrollment-xilonix-tm-110000347.html
*********************************************************
$XBIT charts
basic chart ## source: stockcharts.com
basic chart ## source: stockscores.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$XBIT company information
## source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/XBIT/company-info
Ticker: $XBIT
OTC Market Place: Not Available
CIK code: not found
Company name: XBiotech Inc.
Incorporated In:
$XBIT share structure
## source: otcmarkets.com
Market Value: Not Available
Shares Outstanding: Not Available
Float: Not Available
Authorized Shares: Not Available
Par Value: Not Available
$XBIT extra dd links
Company name: XBiotech Inc.
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/XBIT/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/XBIT/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=XBIT+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=XBIT+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=XBIT+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/XBIT/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/XBIT/news - http://finance.yahoo.com/q/h?s=XBIT+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/XBIT/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/XBIT/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/XBIT/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/XBIT/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/XBIT/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/XBIT/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/XBIT/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/XBIT/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=XBIT+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/XBIT
DTCC (dtcc.com): http://search2.dtcc.com/?q=XBiotech+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=XBiotech+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=XBiotech+Inc.&x=0&y=0
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/XBIT/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/XBIT
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/XBIT/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/XBIT/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/XBIT/sec-filings
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/XBIT/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/XBIT/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/XBIT/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/XBIT/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=XBIT&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=XBIT
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/XBIT/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=XBIT+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=XBIT+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=XBIT
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=XBIT
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=XBIT+Cash+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/XBIT/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=XBIT+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/XBIT.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=XBIT
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/XBIT/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/XBIT/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/XBIT/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/XBIT/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/XBIT
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/XBIT
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/XBIT:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=XBIT
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=XBIT
$XBIT DD Notes ~ http://www.ddnotesmaker.com/XBIT
Recent XBIT News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/12/2024 06:38:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/20/2024 04:57:05 PM
- XBiotech Results from Randomized Double-Blinded Phase 1/2 Study Suggest Potential Breakthrough Treatment for Advanced Pancreatic Cancer • GlobeNewswire Inc. • 06/18/2024 03:35:14 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 03:27:20 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/07/2024 05:36:43 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/07/2024 05:01:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/05/2024 03:48:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/04/2024 02:00:25 PM
- XBiotech to Begin Constructing New R&D Facility on its 48-acre Campus • GlobeNewswire Inc. • 01/04/2024 02:00:00 PM
- XBiotech to Begin Constructing New R&D Facility on its 48-acre Campus • GlobeNewswire Inc. • 01/04/2024 02:00:00 PM
- Dr. Alan Kivitz to Chair XBiotech’s Natrunix Program in Rheumatoid Arthritis • GlobeNewswire Inc. • 11/14/2023 02:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 07:41:46 PM
- XBiotech Announces Enrollment Completion of Phase I Clinical Trial for Hutrukin, a Novel Candidate Therapy for Stroke • GlobeNewswire Inc. • 09/26/2023 01:00:00 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM